SARS-CoV-2-specific IgA antibodies were detected in the saliva and BALF of patients with COVID-19, and SARS-CoV-2 neutralization was more closely correlated with IgA than with IgM or IgG in the first weeks after symptom onset [152]. Here, CD79A is linked to COVID-19.